HIDRADENITIS
Clinical trials for HIDRADENITIS explained in plain language.
Never miss a new study
Get alerted when new HIDRADENITIS trials appear
Sign up with your email to follow new studies for HIDRADENITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill for chronic hives and skin disease tested – but study halted early
Disease control TerminatedThis study tested an oral drug called INF904 in people with moderate to severe chronic spontaneous urticaria (long-term hives) or hidradenitis suppurativa (a painful skin condition). The trial was open-label and lasted 28 days of treatment plus follow-up. It aimed to check safety…
Matched conditions: HIDRADENITIS
Phase: PHASE2 • Sponsor: InflaRx GmbH • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New hope for painful skin condition: experimental drug shows promise
Disease control TerminatedThis study tested a new drug called amlitelimab for adults with moderate to severe hidradenitis suppurativa, a painful skin condition that causes boils and tunnels. About 90 people received either the drug or a placebo for 16 weeks, with an optional long-term extension. The goal …
Matched conditions: HIDRADENITIS
Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC